Urges the department of social services and the office of administration to examine the potential cost savings of providing enhanced coverage for biosimilar drugs for participants in Mo HealthNet and the state employee insurance plan.
||Solon, Sheila (009)
|Proposed Effective Date:
||05/15/2020 - Referred: Health and Mental Health Policy(H)
|Next House Hearing:
||Hearing not scheduled
||Bill currently not on a House calendar